Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

BetterLife Pharma Inc.

Complete process development, scale-up, and initiate GMP manufacturing for AP-001

Not delivered by the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
19 Jan 2021
Due
30 Sep 2021
Checked
25 Oct 2026
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“By Q3 of 2021, the Company plans to have completed process development and scale-up of the AP-001 cream and initiate GMP manufacturing.”

What we found

Evidence strength A What the grades mean

The company reported in December 2021 that it was still in the process of setting up GMP manufacturing for BETR-001, indicating the Q3 2021 deadline for completion was not met.

  • A
    BetterLife Pharma Inc. 6-K filed 2021-12-16 Regulatory filing · published 16 Dec 2021 · retrieved 25 Oct 2026 · kept permanently by the SEC · fingerprint c4f9c0d57cca
    “BetterLife is currently setting up GMP manufacturing of BETR-001.” ✓ confirmed on the page

Market reaction: the shares moved +0.5% against the S&P 500 over the three sessions around the disclosure (15 Dec 2021 to 20 Dec 2021). What this measures

Checked 25 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Product other
Indicative materiality
Low rules
Action
Complete
Deliverable
AP-001 manufacturing process
Language
Expected (“expects”, “plans”)
In the company’s control
High
Specificity
High

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
  4. Third check on a negative finding: agreesBecause a negative finding could harm a company if wrong, a stronger model re-read the evidence fully blind and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you BetterLife Pharma Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-BETRF-022188 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.